Evans Adam G, Chaker Sara C, Curran Gabrielle E, Downer Mauricio A, Assi Patrick E, Joseph Jeremy T, Kassis Salam Al, Thayer Wesley P
School of Medicine, Meharry Medical College, Nashville, TN, USA.
Vanderbilt University, Nashville, TN, USA.
Plast Surg (Oakv). 2022 Aug;30(3):254-268. doi: 10.1177/22925503211019646. Epub 2021 Jun 8.
Individuals with an extremity amputation are predisposed to persistent pain that reduces their quality of life. Residual limb pain is defined as pain that is felt in the limb after amputation. A Preferred Reporting Items for Systematic Reviews and Meta-Analyses-compliant systematic review of 5 databases from inception to June 2020 was performed and is registered under the PROSPERO ID: CRD42020199297. Included studies were clinical trials with residual limb pain assessed at a minimum follow-up of 1 week. Meta-analyses of residual limb pain prevalence and severity were performed with subgroups of extremity and amputation etiology. Twenty clinical trials met criteria and reported on a total of 1347 patients. Mean patient ages ranged from 38 to 77. Residual limb pain prevalence at 1 week, 1 month, 3 months, 6 months, 1 year, and 2 years, respectively, was 50%, 11%, 23%, 27%, 22%, and 24%. Mean residual limb pain severity at the 6 months or longer follow-up was 4.19 out of 10 for cancer amputations, 2.70 for traumatic amputations, 0.47 for vasculopathy amputations, 1.01 for lower extremity amputations, and 3.56 for upper extremity amputations. Residual limb pain severity varies according to the etiology of amputation and is more common after upper extremity amputation than lower extremity amputations. The most severe pain is reported by patients undergoing amputations due to cancer, followed by traumatic amputations, while vascular amputation patients report lower pain severity. Promising methods of reducing long-term pain are preoperative pain control, nerve or epidural blocks, use of memantine, calcitonin-containing blocks, and prophylactic nerve coaptations.
肢体截肢患者易患持续性疼痛,这会降低他们的生活质量。残肢痛被定义为截肢后在残肢上感觉到的疼痛。我们对5个数据库从创建到2020年6月进行了一项符合系统评价和Meta分析的首选报告项目要求的系统评价,并已在国际前瞻性系统评价注册库(PROSPERO)登记,登记号为:CRD42020199297。纳入的研究为残肢痛在至少1周随访时进行评估的临床试验。对残肢痛的患病率和严重程度进行了Meta分析,分析了肢体和截肢病因的亚组情况。20项临床试验符合标准,共报告了1347例患者。患者平均年龄在38至77岁之间。残肢痛在1周、1个月、3个月、6个月、1年和2年时的患病率分别为50%、11%、23%、27%、22%和24%。在6个月或更长时间的随访中,癌症截肢患者的残肢痛平均严重程度为10分制中的4.19分,创伤性截肢患者为2.70分,血管病变截肢患者为0.47分,下肢截肢患者为1.01分,上肢截肢患者为3.56分。残肢痛的严重程度因截肢病因而异,上肢截肢后比下肢截肢更常见。因癌症接受截肢手术的患者报告的疼痛最严重,其次是创伤性截肢患者,而血管性截肢患者报告的疼痛严重程度较低。减少长期疼痛的有前景的方法包括术前疼痛控制、神经或硬膜外阻滞、使用美金刚、含降钙素阻滞以及预防性神经吻合。